Merck Is Up 40% In 2018: What's Driving The Rally?
Nov 29, 2018, 4:11 PMBMO Downgrades Pfizer After Q3 Print, Says Risk-Reward 'Fairly Balanced'
Nov 1, 2018, 10:54 AMBMO Sees Balanced Risk-Reward In Bristol-Myers, Takes Neutral Position
Apr 27, 2018, 3:12 PMBMO's Bearish Stance On Eli Lilly Comes To An End
Apr 13, 2018, 11:00 AMAhead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers
Jul 24, 2017, 3:29 PM